Adaptive Biotechnologies COO Julie Rubinstein reports sale of $897,355.59 in common shares
ADPT•Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 common shares from Oct. 14-16, 2026, and exercised options for the same number of shares at $12.14 each.
1. Shares sold and options exercised
Julie Rubinstein sold 35,643 Adaptive Biotechnologies common shares from Oct. 14-16, 2026, and exercised stock options for 35,643 shares at $12.14 per share. Her direct common stock holdings remained at 377,802 shares, and she held 237,205 remaining stock options.
